Analysis

Analysis

Compass Pathways 2025 Financial Review

Company Overview Compass Pathways plc is a biotechnology company developing COMP360, an investigational synthetic psilocybin therapy for mental...

March 25, 2026 | 1 min read | $CMPS

Analysis

LENZ Therapeutics Q4 FY 2025 Financial Update

Company Overview LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalmic solution) 1.44%...

March 25, 2026 | 1 min read | $LENZ

Analysis

Neurogene Inc. Full Year 2025 Financial Overview

Neurogene is a clinical-stage biotechnology company focused on developing genetic medicines for individuals and families affected by rare...

March 25, 2026 | 1 min read | $NGNE

Analysis

Velo3D 2025 Financial Performance Review

Velo3D, Inc. is an additive manufacturing technology company that transforms aerospace and defense supply chains with metal 3D...

March 25, 2026 | 1 min read | $VELO

Analysis

Fennec Pharmaceuticals 2025 Financial Update

Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company committed to the fight against ototoxicity in cancer patients. The...

March 25, 2026 | 1 min read | $FENC

Analysis

NVIDIA (NVDA) Re-Entry Into China’s AI Chip Market: Products, Policy, Competition, and Investor Impact

NVIDIA (NVDA) is positioning for a potential re-acceleration of data center growth by adapting its AI accelerator lineup...

March 24, 2026 | 26 min read | $NVDA

Analysis

Avalo Therapeutics 2025 Financial Review

Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases. The company’s...

March 24, 2026 | 1 min read | $AVTX

Analysis

WeRide Inc. 2025 Financial Performance Review

WeRide Inc. is a global leader in autonomous driving technology and the first publicly traded robotaxi company. For...

March 24, 2026 | 1 min read | $WRD

Analysis

Surrozen 2025 Financial Results Review

Surrozen is a biotechnology company developing targeted therapeutics that harness Wnt signaling to address sight-threatening ophthalmic conditions. For...

March 24, 2026 | 1 min read | $SRZN